A Study of Belumosudil in People at Risk of Developing Graft-Versus-Host Disease After a Stem Cell Transplant

Abroad (travel likely)RecruitingPHASE2

Conditions

Graft Versus Host Disease · Graft Vs Host Disease · Hematologic Malignancy

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations
  • Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge, New Jersey, United States

    Contact: Study coordinator (Doris Ponce, MD) · 646-608-3739
  • Memorial Sloan Kettering Monmouth (Limited Protocol Activities), Middletown, New Jersey, United States

    Contact: Study coordinator (Doris Ponce, MD) · 646-608-3739
  • Memorial Sloan Kettering Bergen (Limited Protocol Activities), Montvale, New Jersey, United States

    Contact: Study coordinator (Doris Ponce, MD) · 646-608-3739
  • Memorial Sloan Kettering Suffolk-Commack (Limited protocol activity), Commack, New York, United States

    Contact: Study coordinator (Doris Ponce, MD) · 646-608-3739
  • Memorial Sloan Kettering Westchester (Limited Protocol Activities), Harrison, New York, United States

    Contact: Study coordinator (Doris Ponce, MD) · 646-608-3739
  • New York University (Data Collection Only), New York, New York, United States

    Contact: Study coordinator (Jingmei Hsi, MD) · 646-501-4848
  • Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York, New York, United States

    Contact: Study coordinator (Doris M Ponce, MD) · 646-608-3739
  • Memorial Sloan Kettering Nassau (Limited Protocol Activites), Rockville Centre, New York, United States

    Contact: Study coordinator (Doris Ponce, MD) · 646-608-3739
Study leads
  • Doris Ponce, MD

    Principal Investigator

    Memorial Sloan Kettering Cancer Center